-
New agency to speed up drug review process in Taiwan
Taiwan’s health ministry has announced the establishment of the Center for Health Policy and Technology Assessment (CHPTA) with an investment of nearly NT$200 million from the National Health Insurance Administration (NHIA). The CHPTA aims to expedite the review process for newly insured drugs by implementing parallel reviews. Starting from New Year’s Day in 2024, the new system is expected to significantly shorten the time required for reviewing newly insured drugs from an average of 13 months to 6 months. Health Minister Hsueh Jui-yuan emphasized that national health insurance plays a stabilizing role in Taiwanese society and disapproved of major amendments, ruling out the possibility of a "third generation health insurance." He also expressed the belief that drug pricing policies under the health insurance system need reform, making the launch of CHPTA a significant reform effort.2023/12/28 13:27